Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-16

Clinical Trial Update: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lacosamide to placebo in idiopathic generalized epilepsy patients on antiepileptic meds completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2020-04-16